Eli Lilly and Co (LLY)
749.91
-3.50
(-0.46%)
USD |
NYSE |
Nov 21, 16:00
748.85
-1.06
(-0.14%)
After-Hours: 20:00
Eli Lilly Total Assets (Quarterly): 75.61B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 75.61B |
| June 30, 2024 | 71.87B |
| March 31, 2024 | 63.94B |
| December 31, 2023 | 64.01B |
| September 30, 2023 | 57.92B |
| June 30, 2023 | 54.81B |
| March 31, 2023 | 53.16B |
| December 31, 2022 | 49.49B |
| September 30, 2022 | 47.46B |
| June 30, 2022 | 47.06B |
| March 31, 2022 | 46.92B |
| December 31, 2021 | 48.81B |
| September 30, 2021 | 48.19B |
| June 30, 2021 | 47.81B |
| March 31, 2021 | 46.84B |
| December 31, 2020 | 46.63B |
| September 30, 2020 | 43.95B |
| June 30, 2020 | 41.97B |
| March 31, 2020 | 41.10B |
| December 31, 2019 | 39.29B |
| September 30, 2019 | 37.89B |
| June 30, 2019 | 38.67B |
| March 31, 2019 | 38.01B |
| December 31, 2018 | 43.91B |
| September 30, 2018 | 44.63B |
| Date | Value |
|---|---|
| June 30, 2018 | 42.36B |
| March 31, 2018 | 44.36B |
| December 31, 2017 | 44.98B |
| September 30, 2017 | 43.01B |
| June 30, 2017 | 40.95B |
| March 31, 2017 | 37.62B |
| December 31, 2016 | 38.81B |
| September 30, 2016 | 37.59B |
| June 30, 2016 | 36.48B |
| March 31, 2016 | 34.69B |
| December 31, 2015 | 35.57B |
| September 30, 2015 | 36.30B |
| June 30, 2015 | 36.04B |
| March 31, 2015 | 35.65B |
| December 31, 2014 | 36.31B |
| September 30, 2014 | 34.65B |
| June 30, 2014 | 35.02B |
| March 31, 2014 | 34.76B |
| December 31, 2013 | 35.25B |
| September 30, 2013 | 33.97B |
| June 30, 2013 | 33.23B |
| March 31, 2013 | 32.30B |
| December 31, 2012 | 34.40B |
| September 30, 2012 | 34.32B |
| June 30, 2012 | 31.81B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
39.29B
Minimum
Dec 2019
75.61B
Maximum
Sep 2024
51.84B
Average
48.00B
Median
Total Assets (Quarterly) Benchmarks
| Amgen Inc | 90.88B |
| Biogen Inc | 28.31B |
| Johnson & Johnson | 178.29B |
| Viking Therapeutics Inc | 937.89M |
| Moderna Inc | 15.80B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 61.29B |
| Shareholders Equity (Quarterly) | 14.24B |
| Debt to Equity Ratio | 2.185 |
| Current Ratio | 1.273 |
| Net Debt Paydown Yield | -0.31% |